Back to Search Start Over

Chitin oligomers promote lymphoid innate and adaptive immune cell activation.

Authors :
Maia A
Cardona Gloria Y
Fuchs K
Chang TH
Engels P
Zhou M
Hinnenthal T
Rusch E
Gouttefangeas C
Weber ANR
Source :
Journal of leukocyte biology [J Leukoc Biol] 2023 Jul 27; Vol. 114 (2), pp. 180-186.
Publication Year :
2023

Abstract

Chitin is a highly abundant N-acetylglucosamine polysaccharide that has been linked to immune responses in the context of fungal infections and allergic asthma, especially to T helper 2 immune responses. Unfortunately, due to the frequent use of crude chitin preparations of unknown purity and degree of polymerization, there is still great uncertainty about how chitin activates different parts of the human immune system. We recently identified chitin oligomers of 6 N-acetylglucosamine units as the smallest immunologically active chitin motif and the innate immune receptor TLR2 as a primary chitin sensor on human and murine myeloid cells, but the response of further immune cells (e.g. lymphoid cells) to oligomeric chitin has not been investigated. Our analysis of primary human immune cells now shows that chitin oligomers activate immune responses of both innate and adaptive lymphocytes: notably, chitin oligomers activated natural killer cells but not B lymphocytes. Moreover, chitin oligomers induced maturation of dendritic cells and enabled potent CD8+ T-cell recall responses. Our results suggest that chitin oligomers not only trigger immediate innate responses in a limited range of myeloid cells but also exert critical activities across the entire human immune system. This highlights chitin oligomer immune activation as an interesting and broadly applicable potential target for both adjuvant development and therapeutic interference in chitin-mediated pathologies.<br />Competing Interests: Conflict of interest statement. K.F., Y.C.G., C.G., and/or A.N.R.W. were listed as inventors on 2 German patents, which have been discontinued since 2020. There are no further conflicts of interest to declare.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1938-3673
Volume :
114
Issue :
2
Database :
MEDLINE
Journal :
Journal of leukocyte biology
Publication Type :
Academic Journal
Accession number :
37075217
Full Text :
https://doi.org/10.1093/jleuko/qiad044